Safety, blood levels & effects of GLPG0634 in Caucasians & Japanese v1

• Research type

  Research Study

• Full title

  Randomized, double-blind, placebo-controlled, study for the assessment of safety, tolerability, pharmacokinetics, and pharmacodynamics, of multiple oral doses of GLPG0634 in Japanese and Caucasian healthy subjects (HMR code: 13-017)

• IRAS ID

  143558

• Contact name

  Adeep Puri

• Contact email

  apuri@hmrlondon.com

• Sponsor organisation

  Galapagos NV

• Eudract number

  2013-004408-21

• Clinicaltrials.gov Identifier

  NCT02162355

• REC name

  Scotland A REC

• REC reference

  14/SS/0054

• Date of REC Opinion

  22 May 2014

• REC opinion

  Further Information Favourable Opinion